Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Guaifenesin, Doxylamine, and Etafedrine in URI
NCT00857987Phase 3Unknown
- Sponsor
- Azidus Laboratories Limited
- Start
- Apr 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of guaifenesin, doxylamine, etafedrine in upper respiratory tract infection (URI), sponsored by Azidus Laboratories Limited. Status: unknown.
02
Drugs
guaifenesindoxylamineetafedrine
03
Conditions
upper respiratory tract infection (URI)
Beyond the preview
Go deeper on NCT00857987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00857987.